Current studies on the therapy of experimental leukemia.
D000477:Alkylating Agents / Q000627:therapeutic use; D000818:Animals; D000914:Antibodies, Viral; D003561:Cytarabine / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D005622:Friend murine leukemia virus / Q000528:radiation effects; D005998:Glycine / Q000627:therapeutic use; D007942:Leukemia, Experimental / Q000532:radiotherapy / Q000628:therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000628:therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D051379:Mice; D008807:Mice, Inbred BALB C; D008979:Moloney murine leukemia virus; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D011070:Poly I-C / Q000627:therapeutic use; D011160:Porfiromycin / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011714:Pyrans / Q000627:therapeutic use; D011925:Rauscher Virus / Q000528:radiation effects; D012075:Remission, Spontaneous; D013154:Spleen / Q000187:drug effects; D014750:Vincristine / Q000627:therapeutic use; D014779:Virus Replication
D000477:Alkylating Agents; D000914:Antibodies, Viral; D009588:Nitrogen Mustard Compounds; D011687:Purines; D011714:Pyrans; D003561:Cytarabine; D003609:Dactinomycin; D014750:Vincristine; D015122:Mercaptopurine; D011160:Porfiromycin; D011070:Poly I-C; D005998:Glycine